BMO raises Ameriprise Financial stock price target on earnings beat By Investing.com

Ameriprise reported Q1 2026 EPS of $11.26, beating BMO's $10.04 estimate and consensus at $10.21, while revenue came in at $4.81 billion versus $4.72 billion expected. BMO raised its price target to $490 from $470 but kept a Market Perform rating, citing a $25 million CMA termination fee, a lower tax rate, and a 73-cent core earnings beat. Net new assets of $4.2 billion missed the $9.1 billion consensus, and BMO expects additional headwinds from the CMA transition.

Analysis

AMP’s print looks better than the surface headline suggests, but the quality of the beat matters more than the magnitude. The core earnings surprise was driven by revenue mix and cost discipline, yet the asset-gathering miss implies the franchise is still leaking momentum at the margin; that is the more important signal because wealth managers can mask weaker organic flows with market beta for only so long. The market is likely pricing in a smooth normalization, while the next 1-2 quarters may instead show a slower AUM comp and lower operating leverage as transition noise works through the base.

The CMA off-boarding is the key second-order risk: even if the direct revenue impact is manageable, it can cascade into advisor distraction, weaker retention, and lower cross-sell conversion. In an advice-led model with high valuation sensitivity to stable flows, a $3-4B client movement is not just a one-time haircut; it can reset the perceived stickiness of the platform and compress the multiple if subsequent quarters fail to reaccelerate. That makes the current valuation less about earnings power and more about confidence in franchise durability over the next 6-12 months.

Contrarian angle: the stock may still be cheap, but it is cheap for a reason — the market is distinguishing between a strong earnings engine and a truly clean growth story. If the off-boarding is contained and the next two prints show stabilization in net flows, downside from here is likely more muted than the headline flow miss implies. If not, this becomes a classic value trap where estimate cuts arrive first and multiple compression follows.

Key Decisions for Investors

• Hold / underweight AMP for 1-2 quarters rather than adding aggressively; risk/reward is asymmetric only if net flows stabilize, otherwise expect downward EPS revisions and 1-2 turns of multiple compression.
• Sell out-of-the-money AMP calls against existing longs over the next 30-60 days to monetize elevated event premium while the market digests the CMA overhang.
• For new money, prefer a relative-value pair: long BLK or TROW vs short AMP for the next 3-6 months; cleaner flow visibility should outperform if advisor sentiment weakens.
• If AMP gaps down on continued flow anxiety but holds above prior support, consider a small tactical long with a tight stop, targeting a mean-reversion move only if management signals the CMA impact is a one-quarter event.